Although there was no significant change in the expression of PCAF and HLCS, the expression level of GCN5 was reduced, and EHMT-1 was increased in BRCA1-mutated breast cancer (Fig. 4B; P < 0.05). Here, KAT2B is linked to breast carcinoma.